World Outlook for Marine Biotechnology report ( http://www.bharatbook.com/Market-Research-Reports/World-Outlook-for-Marine-Biotechnology.html ) presents the world outlook for marine biotechnology across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

This study is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. If fact, all the current products or services on the market can cease to exist in their present form (i.e. at a brand-, R&D specification, or corporate-image level) and all the players can be replaced by other firms (i.e. via exits, entries, mergers, bankruptcies, etc.), and there will still be an international latent demand for marine biotechnology at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. In the case of this report, the data were reported at the aggregate level, with no further breakdown or definition. In other words, any potential product or service that might be incorporated within marine biotechnology falls under this category. Public sources rarely report data at the disaggregated level in order to protect private information from individual firms that might dominate a specific product-market. These sources will therefore aggregate across components of a category and report only the aggregate to the public. While private data are certainly available, this report only relies on public data at the aggregate level without reliance on the summation of various category components. In other words, this report does not aggregate a number of components to arrive at the “whole”. Rather, it starts with the “whole”, and estimates the whole for all countries and the world at large (without needing to know the specific parts that went into the whole in the first place).

In this report we define the sales of marine biotechnology as including all commonly understood products falling within this broad category, such as appliations of marine transportation, environmental remediation, cosmetics, research, and food, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Aker BioMarine ASA, CP Kelco US, Cyanotech Corp, Elan Corp, and FMC Corp. In addition to the sources indicated below, additional information available to the public via news and/or press releases published by players in the industry (including reports from AMR Research, Global Industry Analysts, Forrester Research, Frost & Sullivan, Gartner, IDC, and MarketResearch.com) was considered in defining and calibrating this category. This report describe the methodology used to create the latent demand estimates for marine biotechnology. Since ICON Group has asked me to apply this methodology to a large number of categories, the rather academic discussion below is general and can be applied to a wide variety of categories, not just marine biotechnology. It's steps are as follows:
Step 1. Product Definition and Data Collection
Step 2. Filtering and Smoothing
Step 3. Filling in Missing Values
Step 4. Varying Parameter, Non-linear Estimation
Step 5. Fixed-Parameter Linear Estimation
Step 6. Aggregation and Benchmarking
Step 7. Latent Demand Density: Allocating Across Cities

Key chapters of this report are as follows:
1 INTRODUCTION 1
2 SUMMARY OF FINDINGS 9
3 ASIA & OCEANA 11
4 EUROPE 48
5 THE AMERICAS & THE CARIBBEAN 85
6 THE MIDDLE EAST & AFRICA 122
7 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 179

For vast range of market reports please visit : http://www.bharatbook.com/Market-Research/Biotechnology.html

Or

Contact us at:

Bharat Book Bureau
Tel: 91 22 27578668
Fax: 91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com

About the Author:
Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies.

Article Stars: http://articlestars.com

Please Rate this Article

5 out of 54 out of 53 out of 52 out of 51 out of 5 

Not yet Rated